<h1 id="upper-gi-bleed">Upper GI Bleed</h1>
<p><strong>Common causes</strong></p>
<ul>
<li>Peptic ulcer disease (PUD): most common (55%)</li>
<li>Esophageal varices</li>
<li>Gastritis</li>
<li>Mallory-Weiss tears</li>
</ul>
<p><strong>Risk Factors</strong></p>
<ul>
<li>Medications<ul>
<li><span class="drug">aspirin</span>, <span class="drug">warfarin</span>, anticoagulant, NSAIDs, glucocorticoids</li>
</ul>
</li>
<li>Coagulopathies</li>
<li>HIV infection</li>
<li>Liver disease</li>
<li>Prior GI bleed</li>
<li>Prior irradiation for prostate/pelvic cancer</li>
<li>Tobacco use</li>
<li>Alcohol use</li>
<li>Vascular disease</li>
</ul>
<p><strong>Mortality from upper GI bleed (UGIB):</strong></p>
<ul>
<li>Peptic ulcer disease (PUD) = 4%</li>
<li>Esophageal varices = 50%</li>
</ul>
<h2 id="physical-exam">Physical Exam</h2>
<ul>
<li>Iron or bismuth ingestion can result in melanotic stool → fecal occult blood negative</li>
<li>Beets ingestion can result in red stool → fecal occult blood negative</li>
<li>Melena occurs with as little as 50 mL of blood in stomach</li>
</ul>
<h2 id="diagnostic-testing">Diagnostic Testing</h2>
<ul>
<li>BUN/Cr</li>
<li>Hematocrit and platelet count</li>
<li>Liver function test</li>
<li>PT/PTT</li>
<li>Type and screen (or cross)</li>
<li>EKG, if significant bleed and/or risk for ACS</li>
</ul>
<h2 id="transfusions">Transfusions</h2>
<ul>
<li><strong>pRBC:</strong> Target hematocrit for:<ul>
<li>Variceal bleed: Goal = 27 (conservative transfusion because of rebleed risk)</li>
<li>Young patient without CV risk: Goal = 25-27</li>
</ul>
</li>
<li><strong>FFP:</strong> Should also be given for patients with coagulopathy and for every 4 pRBC units (add 1 unit FFP per 4 units pRBC)<ul>
<li>Dose: 10-15 cc/kg with 1 unit of FFP containing 200 cc (per Rosen text)</li>
<li>Typical adult dose = 3-4 units FFP</li>
</ul>
</li>
<li><strong>Platelets:</strong> Indicated for platelets &lt; 50K in setting of active bleed<ul>
<li>Dose: 1 pack platelets/10 kg. Typical adult dose = 6 units (&quot;6 pack&quot;) = 1 apheresis unit. 1 pack raises platelet count 5K-10K (per Roberts/Hedges text)</li>
</ul>
</li>
</ul>
<h2 id="medications">Medications</h2>
<p><strong>H2 blockers</strong>: No benefit.
<strong>Proton pump inhibitor (PPI)</strong>: Reduces risk of rebleeding, need for surgical intervention and transfusion. Questionable if mortality reduction.
<strong><span class="drug">Octreotide</span></strong>: Decreases risk for persistent and recurrent bleeding from variceal and nonvariceal bleeding. Decreases need for transfusion. No mortality reduction.</p>
<ul>
<li>Dose: 50 mcg IV bolus and then 50 mcg/hr IV drip</li>
</ul>
<h2 id="likelihood-ratios-of-ugib">Likelihood Ratios of UGIB</h2>
<h3 id="signs">Signs</h3>
<table>
<thead>
<tr>
<th>Finding</th>
<th>+LR</th>
<th>-LR</th>
</tr>
</thead>
<tbody>
<tr>
<td>Melena on exam</td>
<td>25 (4-174)</td>
<td>0.52 (0.42-0.64)</td>
</tr>
<tr>
<td>NG Lavage with blood or coffee grounds</td>
<td>9.6 (4-23)</td>
<td>0.58 (.049-0.70)</td>
</tr>
<tr>
<td>Clots in stool</td>
<td>0.05 (0.01-0.38)</td>
<td>1.2 (1.1-1.2)</td>
</tr>
</tbody>
</table>
<h3 id="labs">Labs</h3>
<table>
<thead>
<tr>
<th>Finding</th>
<th>+LR</th>
<th>-LR</th>
</tr>
</thead>
<tbody>
<tr>
<td>BUN/Cr ratio &gt; 30</td>
<td>7.5 (2.8-12)</td>
<td>0.53 (0.28-0.78)</td>
</tr>
</tbody>
</table>
<h2 id="likelihood-of-severe-bleeding-requiring-intervention">Likelihood of Severe Bleeding Requiring intervention</h2>
<h3 id="history">History</h3>
<table>
<thead>
<tr>
<th>Finding</th>
<th>+LR</th>
<th>-LR</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cirrhosis or malignancy hx</td>
<td>3.7 (1.6-8.8)</td>
<td>0.83 (0.72-0.97)</td>
</tr>
<tr>
<td>Syncope</td>
<td>3.0 (1.7-5.4)</td>
<td>0.95 (0.91-0.98)</td>
</tr>
<tr>
<td>Using analgesics</td>
<td>2.6 (1.3-5.2)</td>
<td>0.92 (0.84-0.99)</td>
</tr>
<tr>
<td>Coffee ground emesis</td>
<td>0.41 (0.26-0.64)</td>
<td>1.1 (1.1-1.2)</td>
</tr>
</tbody>
</table>
<h3 id="signs">Signs</h3>
<table>
<thead>
<tr>
<th>Finding</th>
<th>+LR</th>
<th>-LR</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pulse &gt; 100/min</td>
<td>4.9 (3.2-7.6)</td>
<td>0.34 (0.22-0.53)</td>
</tr>
<tr>
<td>NG lavage with red blood</td>
<td>3.1 (1.2-14)</td>
<td>0.32 (0.17-0.57)</td>
</tr>
<tr>
<td>NG lavage with red blood or coffee grounds</td>
<td>2.0 (1.0-4.0)</td>
<td>0.40 (0.20-0.81)</td>
</tr>
<tr>
<td>Hypotension</td>
<td>1.2-4.8</td>
<td>0.51-0.78</td>
</tr>
</tbody>
</table>
<h3 id="labs">Labs</h3>
<table>
<thead>
<tr>
<th>Finding</th>
<th>+LR</th>
<th>-LR</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hgb &lt; 8 g/dL</td>
<td>4.5-6.2</td>
<td>0.36-0.41</td>
</tr>
<tr>
<td>BUN &gt; 90 mg/dL</td>
<td>3.6 (2.4-5.5)</td>
<td>0.45 (0.31-0.65)</td>
</tr>
<tr>
<td>WBC &gt; 12</td>
<td>3.4 (2.2-5.1)</td>
<td>0.48 (0.34-0.68)</td>
</tr>
</tbody>
</table>
<h2 id="blatchford-score">Blatchford Score</h2>
<p>Validated decision tool to identify UGIB patients who DON&#39;T need urgent intervention</p>
<p><strong>Serum BUN (mg/dL)</strong></p>
<table>
<thead>
<tr>
<th>Finding</th>
<th style="text-align:center">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>&lt; 18.2</td>
<td style="text-align:center">0</td>
</tr>
<tr>
<td>18 - 22.4</td>
<td style="text-align:center">2</td>
</tr>
<tr>
<td>22.4 - 28.0</td>
<td style="text-align:center">3</td>
</tr>
<tr>
<td>28 - 70.0</td>
<td style="text-align:center">4</td>
</tr>
<tr>
<td>&ge; 70.0</td>
<td style="text-align:center">6</td>
</tr>
</tbody>
</table>
<p><strong>Hemoglobin (men, g/dL)</strong></p>
<table>
<thead>
<tr>
<th>Finding</th>
<th style="text-align:center">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>&gt; 13</td>
<td style="text-align:center">0</td>
</tr>
<tr>
<td>12 - 12.9</td>
<td style="text-align:center">1</td>
</tr>
<tr>
<td>10 - 11.9</td>
<td style="text-align:center">3</td>
</tr>
<tr>
<td>&lt; 10</td>
<td style="text-align:center">6</td>
</tr>
</tbody>
</table>
<p><strong>Hemoglobin (women, d/gL)</strong></p>
<table>
<thead>
<tr>
<th>Finding</th>
<th style="text-align:center">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>&gt; 12</td>
<td style="text-align:center">0</td>
</tr>
<tr>
<td>10 - 11.9</td>
<td style="text-align:center">1</td>
</tr>
<tr>
<td>&lt; 10</td>
<td style="text-align:center">6</td>
</tr>
</tbody>
</table>
<p><strong>SBP (mmHg)</strong></p>
<table>
<thead>
<tr>
<th>Finding</th>
<th style="text-align:center">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>&gt; 109</td>
<td style="text-align:center">0</td>
</tr>
<tr>
<td>100-109</td>
<td style="text-align:center">1</td>
</tr>
<tr>
<td>90-99</td>
<td style="text-align:center">2</td>
</tr>
<tr>
<td>&lt; 90</td>
<td style="text-align:center">3</td>
</tr>
</tbody>
</table>
<p><strong>Others</strong></p>
<table>
<thead>
<tr>
<th>Finding</th>
<th style="text-align:center">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pulse &gt; 100/min</td>
<td style="text-align:center">1</td>
</tr>
<tr>
<td>Melena on Exam</td>
<td style="text-align:center">1</td>
</tr>
<tr>
<td>Syncope</td>
<td style="text-align:center">2</td>
</tr>
<tr>
<td>Hepatic disease</td>
<td style="text-align:center">2</td>
</tr>
<tr>
<td>Heart failure</td>
<td style="text-align:center">2</td>
</tr>
</tbody>
</table>
<h3 id="likelihood-ratio-of-need-for-urgent-evaluation-by-score">Likelihood Ratio of Need for Urgent Evaluation by Score</h3>
<table>
<thead>
<tr>
<th>Blatchford Score</th>
<th>+LR</th>
<th>-LR</th>
</tr>
</thead>
<tbody>
<tr>
<td>0</td>
<td>1.2 (1.0-1.3)</td>
<td>0.2 (0-0.05)</td>
</tr>
<tr>
<td>&le; 2</td>
<td>1.4 (1.1-1.8)</td>
<td>0.08 (0.01-0.41)</td>
</tr>
</tbody>
</table>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21515178">Kumar R, Mills AM. GI Bleeding. EM Clin N Am. 2011; 29:239-52.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22416103">Srygley FD et al. Does this patient have a severe UGIB? JAMA. Mar 14, 2012; 307(10):1072-9.</a></li>
</ul>
